Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
06-2019 | 03-2019 | 12-2018 | |
Operating Expenses | 6,999 | 3,841 | 0 |
Operating Income | -6,999 | -3,841 | N/A |
Other Income | -5,288 | 13 | 0 |
Pre-tax Income | -12,287 | -3,828 | 0 |
Net Income Continuous | -12,287 | -3,828 | N/A |
Net Income | $-12,287 | $-3,828 | $N/A |
EPS Basic Total Ops | -5.99 | -1.87 | N/A |
EPS Basic Continuous Ops | -5.99 | -1.87 | N/A |
EPS Diluted Total Ops | -5.99 | -1.87 | N/A |
EPS Diluted Continuous Ops | -5.99 | -1.87 | N/A |
EBITDA(a) | $-6,986 | $-3,829 | $N/A |